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Kajian Pemiawaian Ekstrak daun Ficus deltoidea Jack dan Orthosiphon
stamineus Benth. untuk Kesan Anti-hipertensi dan Anti-angiogenik yang
Terpilih
ABSTRAK
Di Malaysia, Ficus deltoidea (FD) dan Orthosiphon stamineus (OS) telah
digunakan untuk mengubati pelbagai jenis penyakit berkaitan kencing manis,
tekanan darah tinggi keradangan angiogenesis. Oleh itu, kajian ini bertujuan menjana
data dan bukti mengenai pempiawaian dua jenis tumbuhan ubatan yang telah dipilih
iaitu FD dan Orthosiphon stamineus OS.
Kajian ini bertujuan menjana data dan bukti mengenai tekanan darah tinggi dan
angiogenesis memandangan kekurangan maklumat yang berkaitan., dua jenis
tumbuhan ubatan telah dipilih iaitu Ficus deltoidea var. deltoidae (FD) dan
Orthosiphon stamineus (OS).
Dalam kajian ini, analisis gravimetrik dan ujian had mikrob (MLT) telah
dijalankan ke atas serbuk daun kering untuk pemeriksaan kualiti dan keselamatan
bahan mentah. Kedua-dua daun FD dan OS didapati memenuhi syarat kualiti dari
segi sifat fizikokimia dan pencemaran mikrob. Penyaringan fitokimia awal ekstrak
metanol dan ekstrak air daun FD dan OS menunjukkan kehadiran sebatian fenolik,
asid amino, flavonoid, terpenoid dan saponin. Ekstrak OS juga menunjukkan
kehadiran sterol.
Profil kimia yang melibatkan analisis kualitatif dengan teknik spektroskopi
(UV, IR, NIR) dan kromatografi (HPTLC dan GC-MS) dan analisis kuantitatif
xix
dengan teknik kromatografi (HPTLC dan HPLC) telah dijalankan untuk pemiawaian.
Viteksin, isoviteksin, L-sitrulina, L-arginina and asid ursolik telah digunakan sebagai
penanda kimia untuk ujian analitikal FD manakala asid rosmarinik, 3-hidroksi-
5,6,7,4-metoksiflavon, sinensetin, eupatorin, asid oleanolik dan asid ursolik telah
dipilih sebagai penanda kimia untuk OS berdasarkan nilai perubatan dan tahap. Julat
kepekatan flavonoid dalan ekstrak FD ialah antara 5.67 - 18.76 mg/g untuk viteksin
dan 1.06 - 9.50 mg/g untuk isoviteksin. Kepekatan untuk L-sitrulina and L-arginina
dalam ekstrak FD ialah antara 7.45 - 8.53 mg/g untuk L-sitrulina dan 5.36 – 8.44
mg/g untuk L-arginina. Paras asid ursolik dalam ekstrak FD antara 2.46 – 4.27 mg/g.
Asid rosmarinik, konstituen utama ekstrak air OS ialah antara 56.77 mg/g dalam
ekstrak metanol dan 15.92 mg/g dalam ekstrak air. Kepekatan flavon dalam ekstrak
OS ialah antara 5.61 – 33.16 mg/g untuk sinensetin, 0.35 – 10.48 mg/g untuk 3'-
hidroksi-5,6,7,4'-tetrametoksiflavon dan 7.73 – 177.91 mg/g untuk eupatorin. Paras
asid oleanolik dan asid ursolik dalam ekstrak OS adalah di dalam julat  8.70 – 13.22
mg/g dan 2.16 – 33.43 mg/g masing-masing. Metabolit primer dan sekunder untuk
ekstrak FD dan OS telah diuji untuk kandungan jumlah flavonoid, polifenolik,
tannin, protein, polisakarida dan glikosaponin. Ekstrak metanol OS mengandungi
kandungan flavonoid (336.58 mg/g) tertinggi manakala ekstrak air tumbuhan ini
mengandungi jumlah polifenolik (157.00 mg/g) dan polisakarida (10.12%) tertinggi.
Ekstrak metanol FD menunjukkan kandungan tannin (58.10 mg/g) tertinggi.
Kesan in vitro anti-hipertensi ekstrak metanol dan air FD dan OS telah disaring
menggunakan assai ACE-I berasaskan enzim dan kuantifikasi kepekatan ACE dalam
laisat sel-sel endotelium vaskular pusat (HUVEC) selepas dirawat dengan ekstrak.
Ekstrak FD dan OS menunjukkan aktiviti ACE-I yang ketara dalam kedua-dua assai.
Dalam assai enzim, ekstrak metanol FD menunjukkan perencatan yang tertinggi
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sebanyak 96.00% dan nilai IC50 yang terendah (19.15 µg/mL) dan kedua-dua ekstrak
metanol FD dan OS menunjukkan perencatan yang tinggi ke atas ACE dalam laisat
HUVEC (73.51% dan 73.46% perencatan). Kesan anti-angiogenik ekstrak metanol
dan air untuk FD dan OS telah disiasat menggunakan assai in vivo membran
korioalantoik embrio ayam. Keputusan menunjukkan semua ekstrak mempunyai
aktiviti anti-angiogenik yang ketara; bagaimanapun ekstrak metanol FD  telah
memesongkan rangkaian vaskulatur tertinggi pada kepekatan 100 µg/mL. Kesan
sitotoksik ekstrak metanol dan ekstrak air FD dan OS telah dinilai menggunakan
assai MTT terhadap dua sel kanser manusia iaitu karsinoma kolorektum (HCT 116)
dan kanser payudara sensitif hormon (MCF 7). Di samping itu, ekstrak juga diuji ke
atas sel normal manusia (HUVECs). Kedua-dua ekstrak FD dan OS menunjukkan
activiti sitotoksik yang sederhana terhadap sel-sel (IC50 ˃ 20 µg/mL) dan kesan
sitotoksik yang lemah ke atas sel HUVECs, yang mencadangkan bahawa potensi
anti-kanser daun FD dan OS mungkin bukan dari kesan sitotoksiknya tetapi mungkin
disebabkan oleh perencatan angiogenesis.
Kesimpulan, kajian ini membuktikan aktiviti anti-hipertensi dan anti-
angiogenik, kualiti dan keselamatan ekstrak terpiawai FD dan OS. Kaedah HPTLC
dan HPLC dari pada kajian ini boleh digunakan untuk pemiawaian dan analisis lazim
kedua-dua bahan herba FD dan OS.
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Studies on Standardization of Ficus deltoidea Jack and Orthosiphon stamineus
Benth. Leaf Extracts for Selected Anti-hypertensive and Anti-angiogenic Effects
6 ABSTRACT
Ficus deltoidea (FD) and Orthosiphon stamineus (OS) were used traditionally
for treatment of a wide range of diseases related to diabetes, hypertension,
inflammation and angiogenesis related diseases in Malaysia. Therefore, this study
was aimed to generate data and evidence about standardization of two medicinal
plants namely Ficus deltoidea (FD) and Orthosiphon stamineus (OS) for anti-
hypertensive and anti-angiogenesic effects, since there is lack of sufficient scientific
data in this regard.
In this study, gravimetric analysis and microbial limit test (MLT) were applied
on the dried powder of the leaves to examine the quality and safety of the raw
material. Both FD and OS leaves were found to be qualified in terms of
physicochemical properties as well as microbial contamination. Preliminary
phytochemical screening on methanol and water extracts of FD and OS leaves
showed the presence of phenolics, amino acids, flavonoids, terpenoids and saponins
in FD and OS extracts. OS extracts also showed the presence of sterols.
The chemical profile involving qualitative analysis by spectroscopic (UV, IR,
NIR) and chromatographic techniques (HPTLC and GC-MS) and quantitative
analysis by chromatographic techniques (HPTLC and HPLC) were carried out for
standardization. Vitexin, isovitexin, L-citrulline, L-arginine and ursolic acid were
used as markers for the analytical study of FD while, rosmarininc acid, 3-hydroxy-
5,6,7,4-methoxyflavone, sinensetin, eupatorin, oleanolic acid and ursolic acid were
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selected as markers for OS based on their medicinal values and their quantifiable
levels. The concentration range of flavonoids varied in FD extracts from 5.67 - 18.76
mg/g for vitexin and 1.06 - 9.50 mg/g for isovitexin. The concentration of L-
citrulline and L-arginine in FD extracts varied from 7.45 - 8.53 mg/g for L-citrulline
and 5.36 – 8.44 mg/g for L-arginine. The level of ursolic acid in FD extracts varied
from 2.46 – 4.27 mg/g. Rosmarinic acid, the principal constituent of OS water extract
ranges from 56.77 mg/g in methanol and 15.92 mg/g in water extract. The
concentration range of the flavones in OS extracts varied from 5.61 – 33.16 mg/g for
sinensetin, 0.35 – 10.48 mg/g for 3'-hydroxy-5,6,7,4'-tetramethoxyflavone and, 7.73
– 177.91 mg/g for eupatorin. The level of oleanolic acid and ursolic acid in OS
extracts was in the range of 8.70 – 13.22 mg/g and 2.16 – 33.43 mg/g, respectively.
Primary and secondary metabolites of FD and OS extracts were analysed for their
total flavonoids, polyphenols, tannins, proteins, polysaccharides and glycosaponins.
Methanolic extract of OS contained the highest flavonoid (336.58 mg/g) content,
while the water extract of this plant consisted of the highest amount of polyphenolic
(157.00 mg/g) and polysaccharides (10.12%). Methanol extract of FD shows the
highest amount of tannins (58.10 mg/g).
Methanolic and water extracts of FD and OS were screened for their in vitro
antihypertensive effect using enzymatic-based ACE-I assay and quantifying ACE
concentration in umbilical vascular endothelial cells (HUVEC) lysates after treating
with the extracts. FD and OS extracts showed significant ACE-I activity in both
assays. In the enzymatic assay, FD methanolic extract exhibited the highest
inhibition of 96.00% and lowest IC50 value of 19.15 µg/mL and both FD and OS
methanol extracts showed high inhibition on ACE expression in HUVEC lysates
(73.51% and 73.46% inhibition). Antiangiogenic effects of FD and OS methanol and
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water were investigated using in vivo chick chorioallantoic membrane assay. The
results showed that all extracts had significant antiangiogenic activity; however FD
methanolic extract at the concentration of 100 µg/mL distorted the highest
vasculature architecture. Cytotoxic effects of FD and OS methanol and water extracts
were assessed using MTT assay against two human cancer cell lines namely;
colorectal carcinoma (HCT 116) and hormone sensitive breast cancer (MCF 7). In
addition, the extracts were also tested against normal human cell line, (HUVECs).
Both FD and OS extracts showed modest cytotoxic activity against cancer cells (IC50
> 20 µg/mL) and weak cytotoxic effects against HUVECs cells, suggesting that
anticancer potential of the leaves of FD and OS might not be due to its cytotoxic
effect but may be due to the inhibition of angiogenesis.
In conclusion, the current study provides evidence on antihypertensive and
antiangiogenic activities, quality and safety of the standardized FD and OS extracts.
The developed quantitative HPTLC and HPLC methods for this study can be used
for standardization and routine analysis of both FD and OS herbal materials.
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INTRODUCTION
1.1 Significance of Medicinal Plants
Herbs and spices have been used by humans as food source and to treat
ailments for generations. Herbal remedies and herbal products have been used over
4,000 years for partial treatment ailments and diseases. Medicinal herbs were the
primary health care agents for many centuries before the development of modern
medicines. Medicinal plants have played a key role in world’s health. In spite of the
great advances observed in modern medicine in the recent decades, plants still make
an important contribution to health. The consumption of plant-based medicines and
other botanicals has increased manifold in recent years. In spite of many
developments in synthetic chemistry, plants are still used as sources for new drugs
due to the influence of cultural in the use of traditional medicine and also the
potential of the plants. Several well-known medicines were derived from plants such
as morphine, digitoxin, taxol, colchincine, and L-hyoscyamine. Herbal and other
traditional medicines have been used by more that 80% of the world population in
developing countries as the primary health care (Hussain et al., 2009). Encouraging
and promoting the use of traditional and herbal remedies are recommended by World
Health Organization (WHO) in the National Health Care Program (Hussain et al.,
2009).
Herb is defined as a plant or plant part used for its aromatic, savoury, medicinal
or cosmetic properties. Generally, the whole plant or plant parts are used singly or in
combination with more than one plant for the purpose of treatment. According to the
WHO, herbal medicines including plant or plant materials in the crude or processed
2state as active ingredients may contain excipients. Combinations with chemically
defined active substances or isolated constituents are not considered herbal
medicines (WHO Technical Report, 1996). Similarly, the European Medicinal
Evaluation Agency (EMEA) defines herbal medicinal products as the medicinal
products containing exclusively herbal drugs or herbal drug preparations.
Many plants and plant-based products are being used as folk remedies in the
form of fresh or dried plant materials, extracts, tinctures, fatty or essential oils,
expressed juices, processed resins or gums, and so forth prepared from herbal drugs,
preparation whose production involves a fractionation or concentration processes.
Cultivation and utilization of medicinal plants have been increased in spite of many
developments in synthetic chemistry. A single plant contains a large number of
organic chemicals which may include fatty acids, sterols, alkaloids, glycosides,
saponins, tannins and terpenes. The concentration of these substances depends on
various factors related to species variation, seedling growing condition and
production of the herbal products. These chemical compounds can be used as starting
material for synthesis of novel drugs. More than 250,000 species of plants have been
identified but only small percentage of them has been investigated for bioactive
compounds indicating the potential of plants as a source of new drugs (Prance,
1997).
1.2 Efficacy, Safety and Quality Control in the Standardization of Herbal
Medicine
Botanicals herbal preparations are medicinal preparations, containing a single
plant or a mixture of two or more different types of medicinal plants, but the problem
is to determine which components are biologically active. Pharmacological activity
3and the uniformity in herbal products are based on changing chemical constituents
which process the activity and environmental factors of the herbs. To overcome this
situation, consistent products can be created through standardization.
Standardization is a process to maintain consistency in claimed efficacy of a
formulation and its batch to batch reproducibility. Standardization is an important
step to know the active constituents are known. However, for many herbs the active
constituents are not known. In these cases, products may be standardized on the
content of certain ‘markers’ compounds (chemical characteristic of the herb, or
present in large quantities). Despite many proven benefits, natural products could not
get wider acceptance in the main stream of pharmaceuticals due to lack of
standardization. In order to bring these remedies into the mainstream pharmaceutical
market, solid scientific evidence is needed to support the efficacy claims of these
products (Barnes, 2003).
Herbal products are usually perceived safe because of their long-standing use
in various cultures. However, there are case reports of series of adverse events after
administration of herbal products. Unknown effects of some of the medicinal herbs
have been observed for instance allergic reactions, direct toxic effect especially due
to heavy metal poisoning, adverse effects related to herb desired for pharmacological
action against possible mutagenic effects and drug contamination. If herbal
medicines are not properly assessed, they can have a serious risk of adverse effects
and drug-herb and drug-food interactions. Hence, the first priority in herbal research
is assessment of the safety of herbal products. There are various approaches to
evaluate the safety of herbal medicines. The toxic effects of herbal preparation may
be attributed to inherent toxicity of plant constituents, ingredients, manufacturing
4malpractice and contamination (Mosihuzzaman and Choudhary, 2008). Therefore,
the quality control and standardization of raw material and the herbal preparation
themselves should be permanently carried out. The WHO has conducted a number of
International Pharmacopoeia which comprises a collection of recommended
procedures for analysis and specifications on quality control methods for medicinal
plant materials. Examples include macroscopic and microscopic examination,
determination of total ash, acid-insoluble ash and water-soluble ash, determination of
pesticide residue, determination of swelling and foaming index, limit test for heavy
metals, limit test for microorganisms, and test for determination of of extractable
matter, water and volatile matter (WHO, 1977).
It is important to note that several factors can greatly affect the quality control
and consequently the therapeutic value of herbal medicines such as the use of fresh
plants, light exposure, temperature, nutrients, water availability, period and time of
collection, method of collecting, drying, packing, storage, transportation of raw
material, age, part of the plant collected and other factors. Apart from these variable
factors, method of extraction and contamination with microorganism, heavy metals,
pesticides and etc, can also interfere with the quality, safety and efficacy of herbal
drugs (Calixto, 2000).
The information on safety and efficacy of herbs or plant medicine are limited
in a number of ways such as in vitro and in vivo studies, drug interactions, effects in
special populations and toxic reaction (O’Hara et al., 1998). The Food and Drug
Administration (FDA) has categorized about 250 herbs as “generally recognized
safe” (GRAS) is chamomile, echinacea, feverfew, garlic, ginkgo and ginseng based
on their long-term traditional use without significant side effects (O’Hara et al.,
51998). A number of surveys about regulatory issues regarding herbal products have
been conducted by WHO (Ernst, 2002). A global survey accomplished in 2005 into
141 countries which started establishing regulatory authorities for the assessment of
safety and efficacy of herbal medicines. The WHO also specified guidelines to
improve consumer information, good agriculture, pharmacovigilance and collection
practices for herbal medicines (Ko, 1998; Woolf et al., 1994; Vanherweghem et al.,
1993).
Herbal medicinal products (HMPs) consist of hundreds of constituents and
some of them may be very toxic such as digitalis, pyrrolizidine alkaloids, ephedrine
and phorbal esters. Establishing appropriate strategies for the analysis of quality,
safety, efficacy, and the process of standardization of HMPs is always challenging
due to their complexity of constituents, unknown chemicals and variation in
chemical composition, heterogeneity of plant species, plant part, growth conditions,
seasonal cycle, climate, age of the plant and inadequacy or unavailability of
standards and analytical methods. With advancments in analytical methods and
knowledge, standardized, safe and high quality HMPs can be manufactured
successfully.
In this study, two types of local medicinal herbs have been selected, namely
Ficus deltoidea (FD) locally known as ‘mas cotek or secotek emas’ and Orthosiphon
stamineus (OS) locally known as misai kucing for antihypertensive and anti-
angiogenic activities. Ficus deltoidea Jack (Moraceae) is one of the native plants
widely distributed in several countries in Southeast Asia. Different parts of the plant
have been used traditionally for treatment of various kinds of illnesses. Decoction of
the F. deltoidea leaves is used to improve blood circulation and to treat diabetes,
6high blood pressure, heart problems, gout, diarrhea, inflammation, analgesic
conditions, pneumonia, and skin infections. In Sabah, the leaves have been used as
herbal tea for anti-aging and youthful appearance (Fasihudin and Hasmah, 1991).
Orthosiphon stamineus Benth. (Lamiaceae) is a medicial plant grown in South East
Asia and currently cultivated in Indonesia and Malaysia. In Malaysia the leaves of
this plant (misai kucing) have been used traditionally in treating angiogenesis related
diseases, urinary lithiasis, edema, inflammation, eruptive fever, influenza, hepatitis,
jaundice, rheumatism, diabetes and hypertension (Wangner, 1982).
1.3 Justification of the Research
Currently F. deltoidea and O. stamineus, have the potential for different
pharmacological properties. Although a number of products manufactured from F.
deltoidea and O. stamineus are available in the market, there is still lack of
information in terms of chemical components related to pharmacological properties
such as antihypertensive and antiangiogenic activities, quality and safety of the
plants. The basis for the traditional use of these herbs in hypertension and
angiogenesis has not yet been scientifically verified to the best of the researcher’s
knowledge.
1.4 Objectives of the Study
The objectives of this study are as the following:
1) To analyze and characterize F. deltoidea and O. stamineus raw materials
2) To develop and validate analytical methods for chemical profiling and
standardization of F. deltoidea and O. stamineus leaf extracts using suitable
marker compounds.
73) To evaluate the standardized extracts of leaves of F. deltoidea and O. stamineus
for in vitro anti-hypertensive activities.
4) To study the antiangiogenic and cytotoxic properties of F. deltoidea and O.
stamineus standardized leaf extracts.
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LITERATURE REVIEW
2.1 Ficus deltoidea
Ficus deltoidea Jack or mas cotek is a plant derived from Moraceae family.  It
is one of the highly variable species, native and widely distributed in several
countries in Southeast Asia (Burkill, 1996; Corner, 1965). The species is popular as a
traditional medicinal plant in villages and nowadays is used in the modern
pharmaceutical market. The enormous variability of F. deltoidea creates a complex
morphological variation within the species (Asiah et al., 2011). Identification of
varieties within the species is very confusing because features of one variety is
always overlapping with those of the other varieties, and oppositely, features of the
same individual plant sometimes display the different states of characters (Asiah et
al., 2011).
2.1.1 Taxonomy
Family Moraceae
Genus Ficus
Species Deltoidea
Scientific name Ficus deltoidea Jack
Synonyms
Common name
(Starr et al., 2003)
Ficus diversifolia Blume
Mistletoe fig
The family of Moraceae comprises of 53 genera and 1400 species, distributed
in tropical and subtropical zones (Wagner et al., 1999; Starr et al., 2003). The
9Moraceae family are composed of trees, shrubs, subshrubs, less often herbs. The
trees and shrubs terrestrial are usually abscise and sometimes armed with thorns or
prickle (Berg, 2001). The largest genus is Ficus with 759 species and occupies many
habitats from lowland swamps to mountain rainforest and semi-arid areas. They have
a wide range of life forms from lianescent climbers to hemiepiphytes and forest
canopy trees (Clement and Weiblen, 2009).
Ficus deltoidea Jack is an evergreen shrub or a small tree up to 2 m tall,
usually bushy and sometimes epiphytic with aerial roots, often begins its life as an
epiphyte but is not a banyan. The plant loves warmth and humidity, and produces
picturesque aerial roots under such conditions. (Riffle, 1998). Leaves of this plant are
broadly spoon-shaped to obovate, leathery, 2-8 × 1.5-7.5 cm long and have blade thin
to thick, bright green and rust-red to olive brown beneath. F. deltoidea can be
divided into two different groups (female and male) based on the leaf shapes.
Different appearance can be observed between the male and female plants. The male
plant leaves are small in size, long and thin, with red spots on the lower surface of
leaves. While the female plant leaves are bigger, thicker and have oval or round
shape (Kiong et al., 2007). The spots on the lower surface of the leaves are black in
colour instead of red (Osman, 2004 as cited by Kiong et al., 2007)
In the whole genus the leaf shape is the most variable and ranges from elliptical
or lanceolate to obovate or spatulate that, the two latter shapes are more common
than the formers two. The spatulate-shaped leaf form is only regularly
commercialised and cultivated. The leaves are 7.6 cm long, thick, dark green and
leathery, almost succulent, and the ends of the spatulate-shaped leaves usually
contain a shallow notch (Starr et al., 2003). The underside of the leaf is midrib
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forked and generally there is a black spot (gland) at the fork and on the upper side of
the leaves, yellow spots can be observed all over the surface. The fig shapes vary
from spherical to round: peduncle 3-15 × 1-2 mm: basal bract 1 mm: body 5-7 mm
wide and with 1.5 cm across. Figs ripen from dull yellow to orange and red and are
freely produced in pairs (Brickell and Zuk, 1997).
In Peninsular Malaysia, East Malaysia and Kalimantan, F. deltoidea plant is
known as mas cotek, secotek emas, telinga kera, sempit-sempit and agoluran. In
Indonesia, it is known as tabat barito, ara jelatih, ara tunggal, api-api telinga gajah
and api-api telinga kera (Musa, 2006).
In Malaysia the local name of this plant refers to the golden dot (emas or mas)
which can be observed on the upper layer of the leaves. Also the shape of the leaves
is slightly same as the ear of ‘beruk or kera’ (monkey in Malay). The common name
of this plant ‘mistletoe fig’ comes from the habit of the plant as epiphytes often grow
on larger trees. The scientific name, deltoidea, triangularis refers to the shape of the
leaves (Starr et al., 2003).
According to the Malaysian traditional herbalist (Kamarudin and Latiff, 2002),
7 different varieties of F. deltoidea are identified as motleyana, angustifolia,
intermedia, kunstleri, deltoidea, bilobata and terengganuensis.
For the purpose of the analytical and biological study, the variety of deltoidea
(F. deltoidea var. deltoidea) has been selected in this resarch (Figure 2.1)
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2.1.2 Ficus deltoidea Var. deltoidea
Distribution: Malaysia (East Johore, South East Pahang), Lingga Archipelagos,
Bangka, Sumatra, Borneo (Zunoliza, 2009).
Ecology: generally epiphytic in lowland and mountain forest, up to 1200 m
altitude (Kinabalu), also terrestrial on rocks and sea-shores (Zunoliza, 2009).
Morphology: A small shrub smaller fig ripening orange to red. The leaves are
lanceolate and penniveined. A strong distinction of this plant is rugose-angular
(Zunoliza, 2009).
Figure 2.1: Pictures of Ficus deltoidea leaves and fruit
2.1.3 Review of Chemical Constituents of Ficus deltoidea
Various chemical constituents including phenolics, triterpenoids and flavonoids
have been identified from the aerial part of F. deltoidea. Reviews on the identified
chemicals of F. deltoidea are summarized in Table 2.1.
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Table 2.1: Chemical constituents of Ficus deltoidea
Class of compounds Chemical constituents Reference
Flavon-3-ol Gallocatechin [1],
catechin [2], epi
gallocatechin [3], epi
efzelechin [4], epi
catechin [5]
Omar et al., 2011
Flavones Lucenin-2 [6], vicenin-
2 [7], isoschaftoside [8],
schaftoside [9], orientin
[10], vitexin [11],
isovitexin [12]
Omar et al., 2011;
Zunoliza, 2009
Hydroxycinnamates 4-p-coumaroylquinic
acid [13]
Omar et al., 2011
Flavonoids
aglycone
(Flavonols)
Naringenin [14],
quercetin [15], rutin
[16]
Ling et al., 2010
Triterpene β-amyrin cinnamate
[17], lupeol [18],  β-
sitosterol [19], friedelin
[20]
Zunoliza, 2009;
Suryati et al.,
2011
Number in brackets indicate the number of the structure
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Table 2.2: Chemical structure of Ficus deltoidea
R = H, R1 = R2 = R3 = OH, Gallocatechin [1]
R = R1 = H, R2 = R3 = OH, Catechin [2]
R = H, R1 = R2 = R3 = OH, Epi gallocatechin [3]
R = R1 = R3 = H, R2 = OH, Epi efzelechin [4]
R = R1 = H, R2 = R3 = OH, Epi catechin [5] Lucenin-2 [6]
Vicenin-2 [7] Isoschaftoside [8] Schaftoside [9]
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Orientin [10] Vitexin [11] Isovitexin [12]
4-p-coumaroylquinic acid [13] Naringenin [14] Quercetin [15]
O
O
HO
HO
OH
OHO
HO
OH
OH
15
Rutin [16]
β-amyrin cinnamate [17]
Lupeol [18]
β-sitosterol [19]
Friedelin [20]
H
HO
H
H H
H
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2.1.4 Review of Biological and Pharmacological Activities of Ficus deltoidea
F. deltoidea is one of the popular plants in Malay traditional medicine its
pharmacological properties have not been fully studied. Very less publication
indicating scientific findings of this plant have been published. For example F.
deltoidea is reported to have antioxidant, antihypertension, anti-inflammatory, anti-
nociceptive, anti-diabetic, anti-ulcerogenic, anti-melanogenic and wound healing
effects. Therefore, research on pharmacological properties of F. deltoidea becomes a
challenge due to the lack of scientific data about this plant.
Recently Zunoliza (2009) studied the standardized extracts of F. deltoidea
leaves which were divided into five parts: chemical investigation, chemical profiling,
biochemical profiling, stability studies and biological profiling. Five compounds
were isolated that included three triterpenoids, β-amyrin cinnamate, β-sitosterol and
friedelin and two flavonoids, vitexin and isovitexin. In vitro antihypertensive studies
using Angiotensin-Converting Enzyme (ACE) assay showed that the extracts have
potent ACE inhibitory activity on in vitro model. In another study on F. deltoidea
fruit extract showed that, the plant extract demonstrated inhibitory effects towards
ACE activity (Abdullah et al., 2008). Both studies suggested that F. deltoidea may
possess antihypertensive properties.
Antioxidant activity of F. deltoidea extracts has been investigated by several
studies. The methanolic and aqueous extracts of three varieties of F. deltoidea
(terengganuensis, angustifolia and deltoidea) were subjected for antioxidant activity
using in vitro models such as free radical scavenging activity, reduction power of
iron (III), superoxide anion (O2-) scavenging xanthine oxidase (XOD), nitric oxide
(NO) and lipid peroxidation. In this study, content of total polyphenols, flavonoids,
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tannis and their correlation with antioxidant activity were estimated. The results of
this study indicated that methanol and aqueous extracts of different varieties of the
plant exhibited different radical scavenging activities in different models (P < 0.05)
and the activity is comparable to quercetin, rutin, butylated hydroxyanisole (BHA),
ascorbic acid and allopurinol (Zunoliza et al., 2009a).
In another study non-enzymatic and enzymatic antioxidant activity of 13
accessions of aqueous extracts of F. deltoidea were investigated. Different
accessions of F. deltoidea were divided into two groups and generally named as
female and male based on the leaf shape and spots.  For non-enzymatic antioxidant,
several assays were used such as 2,2-diphenyl-1- picrylhydrazil (DPPH) free radical
scavenging assay and ferric reducing antioxidant power (FRAP) assay for total
antioxidant content. However, enzymatic antioxidant was assayed using ascorbate
oxidase, peroxidase, catalase and ascorbate peroxidase. In addition, the content of
total polyphenol, flavonoid, phenolic acid and vitamin C in F. deltoidea leaves
extracts were also analyzed. The results show that extracts from female leaves
contain higher content of polyphenols, flavonoids, phenolic acids and vitamin C than
those extracts from male leaves. Whereas, in most of the assays female leaf extracts
are better than the male leaf extracts. This study suggests that female leaf extract
contained more antioxidant compounds. Therefore, they have better antioxidant
activity than the male leaves (Hakiman and Maziah, 2009).
The antinociceptive activity of aqueous extract of F. deltoidea leaves was
evaluated by three models of nociception, namely, acetic acid-induced abdominal
writhing, formalin-induced paw licking and hot plate test. The results show that
aqueous extract of F. deltoidea leaves possess antinociceptive activity as evident in
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all the three nociceptive models. This activity is attributed to some
pharmacologically active constituents such as flavonoids and tannins which have
been discovered from medicinal plants with significant antinociceptive. Thus, it is
suggested that F. deltoidea can be used in treating conditions associated with painful
conditions (Sulaiman et al., 2008).
The blood glucose lowering effect of F. deltoidea leaf and fruit aqueous
extracts were studied using oral glucose tolerance test. The results demonstrated that
external glucose load significantly reduced post-treatment at 50 mg/kg dosage of the
aqueous extracts of both the leaf and fruit of F. deltoidea. From the brine shrimp
toxicity test, both extracts were found to be non-toxic (Norhaniza et al., 2007).
In another study, the effect of F. deltoidea five different extracts (hot and cold
aqueous extracts, petroleum ether extract, methanol and ethanol extracts) and three
fractions from the methanol extract (acidified-chloroform fraction, bacified-
chloroform fraction and n-butanol) on enhanced basal and insulin-stimulated glucose
uptake into Chang liver cell line were tested using glucose uptake assay. The results
illustrated that, except petroleum ether extract, all F. deltoidea extracts and fractions
have the ability to enhance either basal or insulin-stimulated glucose uptake into the
liver cell line. Ethanol and methanol extracts, and acidified-chloroform and bacified-
chloroform fractions showed ability of insulin-mimetic activity, however, ethanol
extract possess the highest insulin-mimetic activity. Both methanol extract and n-
butanol fraction showed insulin-sensitizing activity while methanol extract possess
the highest activity. Therefore, it is found that F. deltoidea extracts have the ability
of blood glucose lowering effect by the augmentation of glucose uptake into liver
cells (Adam et al., 2009).
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The inhibitory activity of F. deltoidea extracts (hot aqueous, ethanol and
methanol extracts) on α-glucosidase enzyme in the small intestine using in vitro and
in vivo models was also studied. In in vitro study, all the extracts of F. deltoidea
inhibited rat intestine α-glucosidase while in the enzyme kinetics study, all extracts
exhibited a mixed-type inhibition mechanism against the activity of α-glucosidase. In
the animal study, all the extracts reduced postprandial hyperglycemia at a dose of
1000 mg/kg body weight in normal and diabetic rats compared to the control group.
Methanol extract of F. deltoidea showed the highest inhibition of α-glucosidase
followed by the ethanol and hot aqueous extracts. This study suggests that the F.
deltoidea extracts possess antidiabetic property by inhibition of α-glucosidase in the
small intestine (Adam et al., 2010).
Abdullah et al. (2010) evaluated the role of F. deltoidea aqueous extract in the
enhancement of wound healing in experimental rats and also histology study of
healed wounds in rats. In this study, five groups of male Sprague Dawley rats were
experimentally wounded in the trailing neck area. Group 1 animals as a negative
control were treated with sterile deionized water while group 2 rats were treated with
thin layer of blank placebo. Group 3 and 4 were topically dressed with thin layer of
placebo containing 5% and 10% F. deltoidea extracts, respectively. Group 5 wounds
were treated by thin layer of intrasite gel as a positive control. The results showed
that, placebo containing 5% and 10% F. deltoidea extracts significantly accelerate
the rate of wound healing compared to sterile deionized water or dressed with blank
placebo and the activity is comparable with intrasite gel (positive control).
Anti-inflammatory activity of standardized extracts of leaves of three varieties
of F. deltoidea (terengganuensis, angustifolia and deltoidea) was investigated by
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using three in vitro assays namely, lipoxygenase, hyaluronidase and TPA-induced
oedema. For the purpose of standardization, two pharmacologically active markers
(vitexin and isovitexin) have been used to standardize methanol and aqueous extracts
of different varieties of F. deltoidea using high performance liquid chromatography
(HPLC) and also percentages of total proteins and polysaccharides have been
estimated in all plants extracts.  The results indicate that both methanol and aqueous
extracts did not show any inhibition in lipoxygenase assay which refers to antiradical
properties of plant extracts. However, in hyaluronidase and TPA-induced oedema
assays methanol extracts of all three varieties of the plant exhibited moderate
inhibitory activity than the aqueous extracts. Thus, this study illusterated that
methanol extracts of F. deltoidea possess bellow anti-inflammatory properties than
the aqueous extracts. This might be due to the presence of active substances endowed
with anti-inflammatory activity such as polyphenolic components (Zunoliza et al.,
2009b).
Anti-ulcerogenic activity of aqueous extract of F. deltoidea against ethanol-
induced gastric mucosal injury was studied by in vivo model. Twenty four adult male
Sprague-Dawley rats were divided into 4 groups and were pre-treated: group 1
distilled water as negative control, groups 2 and 3 with 250 and 500 mg/kg F.
deltoidea extract, respectively (experimental groups) and group 4 with omeprazole as
positive control 30 minutes before oral administration with absolute ethanol to
generate gastric mucosal injury. After 1 hour, all animals were sacrificed and their
stomachs were rapidly removed and ulcer areas and histological sections of gastric
walls were determined. The results showed less gastric mucosal lesions produced by
ulcerogens after pre-treatment with F. deltoidea or omeprazole. Group 3 rats that
were pre-treated with 500 mg/kg F. deltoidea extract showed more gastric protection
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than 250 mg/kg. From the histological studies, it was confirmed that, those rats
which were pre-treated with distilled water (negative control), markedly showed
extensive and deep gastric mucosal necrotic damage, along with edema and
leucocytes infiltration of the submucosal layer. However, better protection of the
gastric mucosa by marked reduction in ulcer area and absence of oedema and
leukocyte infiltration of submucosa was observed in those rats which were pre-
treated with omeprazole or F. deltoidea extracts. Therefore, this study showed that,
F. deltoidea extract by the comparative significant decreases in ulcer areas and
inhibition of submucosal edema and leucocytes infiltration of submucosal layer
promotes ulcer protection as ascertained (Zahra et al., 2009).
Anti-melanogenic efficacy of F. deltoidea aqueous extract was investigated by
preventing in vitro tyrosinase activity and by suppressing tyrosinase gene expression
in B16F1 melanoma cells model. Different in vitro assays were used in this study
namely, MTT assay for measuring cytotoxicity of the extract, melanin assay,
mushroom tyrosinase inhibition assay, intracellular tyrosinase activity assay and
immunoblot assay. The results of MTT assay showed that highest concentration of
the extract dose not affect cell viability as 0.1% (w/v). F. deltoidea leaf extract
inhibited significantly α-MSH-induced melanin synthesis with dose-dependent
manner by treatment.  The effect of F. deltoidea extract on α-MSH-induced melanin
synthesis was comparable with kojic acid, an effective anti-melanogenic agent, used
as the positive control in this assay. The extract of F. deltoidea inhibited mushroom
tyrosinase activity and intracellular tyrosinase activity of B16F1. The inhibition of
intracellular tyrosinase activity was analyzed by immunoblot and tyrosinase
zymography. It was found to be exerted at the protein expression level. F. deltoidea
extract also showed the ability of reduction of the expression of microphthalmia-
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associated transcription factor (MITF). Therefore, this study finds that F. deltoidea
leaf extract are able to inhibit tyrosinase enzyme activity directly by down-regulation
of the expression of genes involved in the melanogenesis pathways. In conclusion, F.
deltoidea leaves have strong anti-melanogenic activity and also the potential to be
used as novel depigmenting agents for cosmetic (Oh et al., 2011).
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Table 2.3: Summary of literatures on biological and pharmacological activity of Ficus deltoidea
Part of
plant
Type of
extract
Biological
activity
Methodology
Compounds
contribute
Reference
Leaf
Methanolic
and aqueous
extracts
Antioxidant
In vitro assays: free radical scavenging activity,
reduction power of iron (III), superoxide anion (O2-),
scavenging xanthine oxidase (XOD), nitric oxide (NO)
and lipid peroxidation
Polyphenol
Flavonoids
Tannins
Zunoliza et
al., 2009a
Aqueous
extract
Non enzymatic in vitro assays: 2,2-diphenyl-1-
picrylhydrazil (DPPH) free radical scavenging assay and
ferric reducing antioxidant power (FRAP) assay for total
antioxidant content
Enzymatic in vitro assays: ascorbate oxidase,
peroxidase, catalase and ascorbate peroxidise
Polyphenol
Phenolic acid
Flavonoids
Hakiman
and
Maziah,
2009
Leaf Aqueous
extract
Anti-
inflammatory
In vitro assays: lipoxygenase, hyaluronidase and TPA-
induced oedema.
Total proteins
Total
polysaccharides
Total poly
phenols
Zunoliza et
al, 2009b
Leaf Aqueous
extract
Antinociceptive In vivo assays: acetic acid-induced abdominal writhing,
formalin-induced paw licking and hot plate test
Flavonoids
Tannins
Sulaiman et
al., 2008
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Fruit Aqueous
extract
Antidiabetes In vivo assay: oral glucose tolerance Flavonoids
Tannins
Norhaniza
et al., 2007
Leaf
Hot and cold
aqueous
extracts,
petroleum
ether, ethanol
and methanol
extracts
Antidiabetes
In vitro assay: Screened of insulinotrophic properties,
using rat pancreatic β-cell lines (BRIN-BD11 cells) and
cytotoxocity effect of plant extracts on the cell.
Flavonoids
Tannins
Hamid et
al., 2008
Hot and cold
aqueous
extracts,
petroleum
ether, ethanol
and methanol
extracts
In vitro assay: glucose uptake assay
In vivo assay: α-glucosidase inhibition
Assay
Flavonoids
Tannins
Adam et
al., 2009
Hot aqueous,
ethanol and
methanol
extracts
In vivo assay: the effect of extracts on postprandial blood
Glucose levels following sucrose loading in normal and
diabetic rats
Flavonoids
Tannins
Adam et
al., 2010
